General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
NCT Number: NCT05035485
The purpose of this study is to investigate the maternal cardiac output response to rescue norepinephrine and phenylephrine boluses for postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Yinchuan, Ningxia, China
Preeclampsia, which affects 5% to 7% of parturients, is a significant cause of maternal and neonatal morbidity and mortality. Because of constricted myometrial spiral arteries with exaggerated vasomotor responsiveness, though blood pressure in parturients with preeclampsia are apparently higher than healthy parturients, placental hypoperfusion is more common. Spinal anesthesia is still the preferred mode of anesthesia in parturients with preeclampsia for cesarean section. In preeclampsia parturients, spinal anesthesia improve intervillous blood flow (provided that hypotension is avoided) which contribute to increase placental perfusion. Even so, 17-26% parturients with preeclampsia experienced postspinal anesthesia hypotension due to the extensive sympathetic block that occurred with spinal anesthesia. As a potential substitute drug for phenylephrine and ephedrine, norepinephrine has gained traction for use in parturients undergoing cesarean section. However, hemodynamic effects of the rescue norepinephrine bolus is still unknown. The purpose of this study is to investigate the maternal cardiac output response to rescue norepinephrine and phenylephrine boluses for postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A rescue phenylephrine (75μg) was given when postspinal anesthesia hypotension occurred within 30 minutes after spinal anesthesia
Other names: Vasopressors
A rescue norepinephrine (6μg) was given when postspinal anesthesia hypotension occurred within 30 minutes after spinal anesthesia
Other names: Vasopressors
Time frame: 1-30 minutes after spinal anesthesia.
Evaluated by the VIGILCO monitoring system.
Time frame: 1-30 minutes after spinal anesthesia
Evaluated by the VIGILCO monitoring system.
Time frame: 1-30 minutes after spinal anesthesia
Evaluated by the VIGILCO monitoring system.
Time frame: 1-30 minutes after spinal anesthesia
Evaluated by performance error (PE)
Time frame: 1-30 minutes after spinal anesthesia
Evaluated by performance error (PE)
Time frame: 1-30 minutes after spinal anesthesia.
Systolic blood pressure (SBP) < 80% of the baseline
Time frame: 1-30 minutes after spinal anesthesia.
Systolic blood pressure (SBP) < 60% of the baseline
Time frame: 1-30 minutes after spinal anesthesia
Presence of nausea and vomiting in patients after spinal anesthesia
Time frame: 1-30 minutes after spinal anesthesia
Heart rate < 60 beats/min.
Time frame: 1-30 minutes after spinal anesthesia
Systolic blood pressure (SBP) >120% of the baseline.
Time frame: Immediately after delivery
From umbilical arterial blood gases.
Time frame: Immediately after delivery
From umbilical arterial blood gases.
Time frame: Immediately after delivery
From umbilical arterial blood gases.
Time frame: 1 min after delivery
A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
Time frame: 5 min after delivery
A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
General Hospital of Ningxia Medical University
Other
Maternal Cardiac Output Response to Rescue Norepinephrine and Phenylephrine Boluses During Spinal Anesthesia for Caesarean Section in Patients With Severe Preeclampsia: a Randomized, Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03755843
Edema, Female Urogenital Diseases and Pregnancy Complications
Mexico City, Mexico
View Trial DetailsNCT06043505
Hemodynamic Instability, Infections
Nîmes, France
View Trial DetailsNCT05705115
Fluid Loss, Hemodynamic Instability
Oslo, Norway
View Trial DetailsNCT06270485
Cardiovascular Abnormalities, Cardiovascular Diseases
Berlin, State of Berlin, Germany
View Trial Details